Lannett Company Inc. has agreed to buy UCB SA’s Kremers Urban Pharmaceuticals Inc. for $1.23 billion. The deal, with tax benefits expected to top $100 million, also calls for potential […]

A year ago Shire shares were punished when the U.S. Treasury’s freeze on so-called inversion transactions nixed the company’s sale to AbbVie, a Chicago-based pharma giant looking to save money on […]